Nktx stock forecast.

Valuation metrics show that Nkarta, Inc. may be fairly valued. Its Value Score of C indicates it would be a neutral pick for value investors. The financial health and growth prospects of NKTX ...

Nktx stock forecast. Things To Know About Nktx stock forecast.

One of the most compelling stocks with 100% upside potential, NKTX nevertheless requires significant patience. Since the beginning of this year, shares plunged almost 22%. In the past 365 days ...Nkarta Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NKTX updated stock price target summary. ... Stock Price Target NKTX. High $ 25.00: Median $ 14.00: Low $ 9.00 ...... stock. We will apply for listing of our common stock on the Nasdaq Global Market under the symbol “NKTX.” We expect that the public offering price will be ...About the Nkarta, Inc. stock forecast. As of 2023 October 17, Tuesday current price of NKTX stock is 1.495$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).

In December 2022, Nkarta had US$352m in cash, and was debt-free. Looking at the last year, the company burnt through US$104m. So it had a cash runway of about 3.4 years from December 2022. There's ...$ 1.898326 1-Month Prediction $ 1.713021 3-Month Prediction Unlock 6-Month Prediction Unlock 1-Year Prediction Unlock Loading... According to our current NKTX stock …

News Nkarta Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-2.50 Market Cap $128.57 M Shares Outstanding 49.07 M …

On June 22, six executives sold a total of 4,033 shares of Nkarta, including CEO Paul Hastings, who sold 1,704. While company insiders often sell stock for various reasons, the timing of the sales ...IOBT Stock 12 Months Forecast. $9.00. (837.99% Upside) Based on 3 Wall Street analysts offering 12 month price targets for IO Biotech in the last 3 months. The average price target is $9.00 with a high forecast of $10.00 and a low forecast of $8.00. The average price target represents a 837.99% change from the last price of $0.96.Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $68.19M. -89.4%. Market Cap / Employee. The market cap of a ...Nkarta Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NKTX updated stock price target summary. ... Stock Price Target NKTX. High $ 25.00: Median $ 14.00: Low $ 9.00 ...

On average, 3 Wall Street analysts forecast NKTX's revenue for 2027 to be $1,429,624,539, with the lowest NKTX revenue forecast at $181,567,665, and the …

0 Oppenheimer Downgrades Nkarta to Perform Best Analysts Covering Nkarta Most Accurate Analysts Most Profitable Analysts Which Analyst Should I Follow If I Want to …

Analyst Price Forecast Suggests 852.85% Upside. As of June 2, 2023, the average one-year price target for Nkarta is 26.78. The forecasts range from a low of 18.18 to a high of $33.60. The average ...Written by Zacks Equity Research for Zacks ->. Nkarta, Inc. NKTX announced that the FDA has cleared the investigational new drug (IND) application to move its investigational candidate, NKX019 ...Find the latest Xometry, Inc. (XMTR) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Get the latest Nkarta Inc (NKTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Preliminary cancer treatment data is pushing the stock higher today. Nkarta (NASDAQ: NKTX) stock is rocketing higher on Monday after the company released preliminary data from a Phase 1 clinical ...If you're new to stock investing, here's how to buy Jaguar Health stock. What is JAGX's forecast return on assets (ROA) for 2023-2023? (NASDAQ: JAGX) forecast ROA is -3,020.59%, which is lower than the forecast US Biotechnology industry average of -6.75%.The latest price target for . Nkarta (NASDAQ: NKTX) was reported by Mizuho on November 16, 2023.The analyst firm set a price target for $9.00 expecting NKTX to rise to within 12 months (a possible ...

Nov 10, 2023 · Nkarta's earnings are forecast to decline at 9.2% per annum while its annual revenue is expected to grow at 77.8% per year. EPS is expected to grow by 7.3% per annum. Term Box: Best Nkarta Inc forecast, NKTX stock price prediction, NKTX forecast, Nkarta Inc finance tips, NKTX prediction, Nkarta Inc analyst report, NKTX stock price predictions 2023, Nkarta Inc stock forecast, NKTX forecast tomorrow, Nkarta Inc technical analysis, NKTX stock future price, Nkarta Inc projections, Nkarta Inc market prognosis, NKTX expected stock price.Analyst Price Forecast Suggests 852.85% Upside. As of June 2, 2023, the average one-year price target for Nkarta is 26.78. The forecasts range from a low of 18.18 to a high of $33.60. The average ...$3.33. BLNK 3.42%. Nkarta Inc. $2.72. NKTX 3.03%. Aclaris Therapeutics Inc. $0.90. ACRS 3.30%. Innate Pharma SA. $2.44. IPHA 1.67%. Ventyx Biosciences Inc.Being prepared to weather a hurricane — whether that involves fortifying your home or creating an emergency evacuation plan — is an important part of making it through the storm. Hurricanes travel across the ocean via massive, circular gust...

Find the latest dividend history for Nkarta, Inc. Common Stock (NKTX) at Nasdaq.com.

The average Upstart Holdings stock price prediction forecasts a potential downside of 2.01% from the current UPST share price of $26.76. What is UPST's forecast return on equity (ROE) for 2023-2026? (NASDAQ: UPST) forecast ROE is …When Nkarta last reported its balance sheet in June 2022, it had zero debt and cash worth US$413m. Looking at the last year, the company burnt through US$78m. That means it had a cash runway of ...Gas prices are at a record high, and experts are forecasting that prices could go higher this summer — perhaps $5 or even over $6 a gallon. By clicking "TRY IT", I agree to receive newsletters and promotions from Money and its partners. I a...The consensus price target of analysts on Wall Street is $14.13, which implies an increase of 80.75% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $9.00 and $25.00 respectively. As a result, NKTX is trading at a discount of -819.12% off the target high and -230.88% off the low.NKTX | Oversold Healthcare Play | LONG Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific p Nkarta, Inc., a a clinical-stage biopharmaceutical ... The average price target for Macy's is $14.83. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $19.00 ,the lowest forecast is $10.00. The average price target represents -0.07% Decrease from the current price of $14.84.Find the latest Sunshine Biopharma, Inc. (SBFM) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...

Jul 31, 2023 · Nkarta (NASDAQ:NKTX) is a biopharmaceutical company that develops engineered natural killer (NK) cell therapies to treat cancer. NK cells are a type of immune cell that can recognize and kill ...

Vertex Energy Inc () Stock Market info Recommendations: Buy or sell Vertex Energy stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Vertex Energy share forecasts, stock quote and buy / sell signals below.According to present data Vertex Energy's VTNR shares and potentially its market environment have …

Jun. 27, 2023, 10:25 AM. In a report released today, Gil Blum from Needham maintained a Buy rating on Nkarta ( NKTX – Research Report ), with a price target of $19.00. The company’s shares ...Nkarta, Inc. Stock Earnings. The value each NKTX share was expected to gain vs. the value that each NKTX share actually gained. Nkarta, Inc. ( NKTX) reported Q3 2023 earnings per share (EPS) of -$0.52, beating estimates of -$0.67 by 22.07%. In the same quarter last year, Nkarta, Inc. 's earnings per share (EPS) was -$0.58. Weather forecasts are essential tools for planning our daily activities, especially when it comes to the next 10 days. Understanding a weather 10 day forecast can help us make informed decisions about outdoor events, travel plans, or even w...It has underperformed other stocks in the Biotechnology industry by 0.45 percentage points. Nkarta stock is currently +97.66% from its 52-week low of $1.28, and -72.62% from its 52-week high of $9.24. As of Nov 20, 2023, there are 49.07M shares of NKTX outstanding. The market cap of NKTX is $124.15M. In the past 24 hours, 524,249 NKTX shares ...According to the issued ratings of 7 analysts in the last year, the consensus rating for Nektar Therapeutics stock is Reduce based on the current 2 sell ratings, 4 hold ratings and 1 buy rating for NKTR. The average twelve-month price prediction for Nektar Therapeutics is $3.00 with a high price target of $6.00 and a low price target of $1.00.IOBT Stock 12 Months Forecast. $9.00. (837.99% Upside) Based on 3 Wall Street analysts offering 12 month price targets for IO Biotech in the last 3 months. The average price target is $9.00 with a high forecast of $10.00 and a low forecast of $8.00. The average price target represents a 837.99% change from the last price of $0.96.Nkarta (NKTX) Company Description: Nkarta Inc is a bio-pharmaceutical company focused on the discovery, development and commercialization of engineered, allogeneic, and off-the-shelf cell ...Find the latest Dalrada Financial Corporation (DFCO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...The Nkarta stock forecast for tomorrow is $ 1.934144, which would represent a 1.73% gain compared to the current price. In the next week, the price of NKTX is expected to decrease by -0.16% and hit $ 1.898326. As far as the long-term Nkarta stock forecast is concerned, here’s what our ...

(See NKTX stock forecast) To find good ideas for penny stocks trading at attractive valuations, visit TipRanks’ Penny Stock Screener. Disclaimer: The opinions expressed in this article are ...The average Io Biotech stock price prediction forecasts a potential upside of 693.62% from the current IOBT share price of $1.05. What is IOBT's forecast return on ...The average Io Biotech stock price prediction forecasts a potential upside of 693.62% from the current IOBT share price of $1.05. What is IOBT's forecast return on ...Instagram:https://instagram. how do i invest in artcvx earning datewhat is inverted yield curveunited states one dollar coin 1979 14,305.03 +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Nkarta, Inc. (NKTX) NasdaqGS - NasdaqGS Real Time Price.... Stock Price Forecast. The 13 analysts offering 12-month price forecasts for Macy's Inc have a median target of 15.00, with a high estimate of 19.00 and a low estimate of 11.00. The median estimate ... best real estate investing websitestechy stock Nov 30, 2023 · Wall Street Analysts Predict a 209% Upside in Nkarta, Inc. (NKTX): Here's What You Should Know. 06/07/22-8:55AM EST Zacks. NKTX | Oversold Healthcare Play | LONG Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific p Nkarta, Inc., a a clinical-stage biopharmaceutical ... usdu Based on 10 Wall Street analysts offering 12 month price targets for Livent in the last 3 months. The average price target is $25.30 with a high forecast of $35.00 and a low forecast of $19.00. The average price target represents a 84.00% change from the last price of $13.75. Highest Price Target $35.00. Average Price Target $25.30.Nkarta (NKTX) Stock Forecast & Price Prediction Estimation of the future price movement of Nkarta stock, based on various factors such as historical price trends, market trends, …Better trading starts here. Nkarta, Inc. (NKTX) Price Targets Enter Symbol Price Target Based on short-term price targets offered by seven analysts, the average …